Release Date: 30/09/13 11:14 Summary: Changes relating to buy-back - Appendix 3D Price Sensitive: Yes Download Document 303.52KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling